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Via their integration of the intermediate ®lament
cytoskeleton into the cell membrane, desmosomes
facilitate the maintenance of cell shape and tissue
integrity as well as intercellular communication. The
transmembrane components of the desmosome, the
desmogleins and desmocollins, are members of the
cadherin family of cell±cell adhesion molecules. Each
of these proteins exists as three distinct isoforms,
which are the products of individual genes and
expressed in a cell-type and differentiation-speci®c
manner. Previous work has suggested that desmo-
glein 1 binds to its catenin partner, plakoglobin, in
an approximately 6:1 stoichiometry. In this study,
the molecular organization of complexes formed by
plakoglobin and desmoglein 1, 2, or 3 are further
examined through immunoprecipitation, size exclu-
sion chromatography and sucrose density sedimenta-
tion analysis. It is shown that the complex formed
between plakoglobin and desmoglein 1 has an overall
molecular weight greater than that of plakoglobin/
desmoglein 2 or plakoglobin/desmoglein 3; however,
the stoichiometry of the plakoglobin/desmoglein 1
complex does not appear to exceed 2:1. Key words:
desmocollin/desmoglein/plakoglobin. J Invest Dermatol
117:1302±1306, 2001
D
esmosomes (from the Greek desmo = bound) are
specialized structures necessary for the establishment
and maintenance of adhesion in tissues of epithelial
origin. These intercellular junctions serve both to
integrate the intermediate ®lament cytoskeleton into
the cell membrane and to establish tight adhesive points between
opposing cells, thereby contributing to the maintenance of
mechanical integrity and resistance to stress, both of the individual
cell and of the multicellular sheet (Green and Gaudry, 2000). The
transmembrane components of the desmosome, the desmogleins
(Dsg) and desmocollins (Dsc), belong to the cadherin superfamily of
cell±cell adhesion mediators. These type I membrane glycoproteins
each exist as three distinct isoforms, termed Dsg1±3 and Dsc1±3,
which are the products of different genes and are expressed in a
cell-type and differentiation-speci®c manner (reviewed in Angst
et al, 2001). At their intracellular aspects, the desmogleins and
desmocollins bind the catenin family member, plakoglobin.
Plakoglobin in turn binds directly to the N-terminus of the plakin
protein, desmoplakin. Desmoplakin bridges the desmosomal
cadherin/catenin complex to the intermediate ®lament cytoskele-
ton through interactions between intermediate ®laments and the
desmoplakin C-terminus (reviewed in Green and Gaudry, 2000).
The intracellular portion of classical cadherins is divided into two
domains: an intracellular anchor domain, followed by a region
known as the intracellular cadherin segment. Sequences in the
intracellular cadherin segment domain are well-conserved, and
have been shown to be responsible for binding to members of the
catenin family. In the case of the desmogleins, three additional
domains, a proline-rich linker (L), a repeating unit domain, and a
desmoglein terminal domain lie downstream of the intracellular
cadherin segment. The function of these three desmoglein-unique
domains is unknown. Residues critical for binding of plakoglobin
to the desmogleins have been mapped to a region toward the end of
the desmoglein intracellular cadherin segment (Marthur et al, 1994;
Roh and Stanley, 1995; Chitaev et al, 1998).
The signi®cance of three isoforms of desmoglein and three
isoforms of desmocollin is not known, and their pro®le of
expression is complex. In the basal-most layer of the skin, Dsg2
and Dsc2, as well as Dsg3 and Dsc3 are present (Koch et al, 1992;
Arnemann et al, 1993; Theis et al, 1993; Shimizu et al, 1995).
Dsg2/Dsc2 levels decrease, and Dsg3/Dsc3 levels increase as the
cells differentiate in the suprabasal layers. Dsg1/Dsc1 levels are
lowest in the basal layer and increase steadily toward the surface of
the skin, as expression of the other isoforms decreases (King et al,
1995; Shimizu et al, 1995; North et al, 1996).
The relevance of desmoglein function to epidermal integrity is
underscored by the existence of the blistering diseases, pemphigus
foliaceus and pemphigus vulgaris (Amagai, 1999) In pemphigus
foliaceus, autoantibodies against Dsg1 cause blistering in the upper
layers of the epidermis. In pemphigus vulgaris, antibodies against
either Dsg3, resulting in mucosal dominant pemphigus vulgaris
with little involvement of the skin, or Dsg3 and Dsg1, resulting in
epithelial acantholysis in both skin and mucosal tissues, have been
shown to be the causative agents (Amagai, 1999). In addition,
staphylococcal scalded skin syndrome, a disorder marked by
sloughing of the super®cial epidermis, is now known to result
from the proteolysis of the Dsg1 extracellular domain by the
Staphylococcus aureus exfoliative toxin a (Amagai et al, 2000). Finally,
a genetic variant of the autosomal dominant disorder striate
palmoplantar keratoderma is known to result from a mutation
leading to N-terminal deletion in the extracellular domain of Dsg1
(Rickman et al, 1999).
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The classical cadherin family member, E-cadherin, has been
shown to interact with its catenin binding partners, plakoglobin and
b-catenin, at a 1:1 stoichiometric ratio (Ozawa and Kemler, 1992).
In contrast, previous work on the desmosomal cadherins has
indicated that in an assay based on recognition of similar epitope
tags, Dsg1 bound plakoglobin in the order of 6:1, whereas Dsc2a
appeared to interact with plakoglobin in a 1:1 ratio (Kowalczyk
et al, 1996). A similar result was suggested by a metabolic labeling
study in which Dsg1 was determined to be bound to 7-fold more
plakoglobin than was Dsc1 (Witcher et al, 1996); however, this
study established fold differences, rather than actual stoichiometric
ratios of either plakoglobin/Dsg1 or plakoglobin/Dsc1 complexes.
The signi®cance of multiple desmosomal cadherin isoforms to
the regulation of junction assembly and epidermal homeostasis is
not well understood. Because the ability to bind varying amounts of
plakoglobin may be a way in which the isoforms exhibit speci®c
control over these processes, we employed metabolic labeling,
sucrose gradient sedimentation and gel ®ltration chromatography to
compare the stoichiometry of plakoglobin/Dsg1 complexes with
those of the other desmoglein isoforms. The analysis revealed that,
although the plakoglobin/Dsg1 complex is larger than that formed
by the other desmoglein isoforms, the previously de®ned 6:1
stoichiometry is likely the result of a difference in antibody
recognition of the epitope tag used to determine protein levels.
Together our data suggest that neither the plakoglobin/Dsg2 nor
plakoglobin/Dsg3 stoichiometries exceed 1:1, and that the
plakoglobin/Dsg1 stoichiometry does not appear to exceed 2:1.
MATERIALS AND METHODS
Generation of cDNA constructs Creation of the full-length Dsg2
construct is described elsewhere (Ishii et al, 2001). Creation of other
constructs used in these experiments is described elsewhere: FLDsg1 in
RC4B and FLPg in b-actin described in (Kowalczyk et al, 1994), human
myc-tagged Dsg3 in b-actin and EcadDsg3 in pcDNA1 (Invitrogen
Corp., Carlsbad, CA) were gifts from Dr J. Stanley and C. Andl.
Mammalian cell culture Mouse L-cell ®broblasts (gift from Dr J.
Stanley) were cultured in Dulbecco's minimal Eagle's medium
(Mediatech, Hernden, VA) containing 10% fetal bovine serum
(Mediatech) and 1% penicillin/streptomycin (Gibco BRL, Gaithersburg,
MD).
Establishment of stable cell lines All stable cell lines were generated
by calcium phosphate transfection as previously described (Kowalczyk
et al, 1994). Cells were transfected on day 1, rinsed ®ve times in
complete phosphate-buffered saline on day 2. On day 3, single colonies
of approximately 1±2 mm in diameter were selected with glass cloning
cylinders and plated into selection medium (Dulbecco's minimal Eagle's
medium complete supplemented with 400 mg per ml G418 (Gibco
BRL). Stable L-cell lines were generated by transfection with the
following constructs: (i) 743 linesÐFLDsg2.myc in RC4B (p743) with
FLPg.myc (p330); (ii) 3299 linesÐFLDsg1.myc in RC4B (p281) with
p743 and p330; (iii) 903 linesÐFLDsg3.myc in pcDNA1amp (p903); (iv)
790 lines±FLEcad.Dsg3.myc in pcDNA3 (p790) with p330; (v) Dsg1
lines±p281 with p330; and (vi) Dsc2 linesÐFLDsc2.myc (p397) with
p330.
Immunoprecipitation and metabolic labeling Methods for
immunoprecipitation and metabolic labeling experiments and
immunoblot analysis (Norvell and Green, 1998), were described
previously. Data for all metabolic labeling/immunoprecipitation
experiments were corrected for met/cys content.
Antibodies The 9E10.2 monoclonal antibody was harvested as
supernatant from hybridoma obtained from ATCC (Evan et al, 1985),
and concentrated over Gamma Bind Plus Sepharose. Rabbit polyclonal
antibody directed against a c-myc peptide (polymyc) was a gift from Dr
J. Stanley. The polyclonal chicken anti-plakoglobin antibody, 1407, was
generated at Aves Labs (Eugene, OR) against recombinant myc tagged
human plakoglobin harvested from Escherichia coli. (Note: this antibody
has secondary recognition of myc epitope tags, as it was generated
against a myc-tagged recombinant protein.) The rabbit polyclonal 795
antibody, directed against the extracellular domain of E-cadherin, was a
gift from Drs Robert Brackenbury and Randall Marsh. The mouse
monoclonal anti-E-cadherin antibody, DECMA-1, was obtained from
Sigma (St Louis, MO). The human pemphigus foliaceus antibody, 982,
was a gift from Dr. J. Stanley; mouse monoclonal 6D8 against human
Dsg2 (Bornslaeger et al, 1996) (Wahl et al, 1996), and mouse monoclonal
18D4 against human Dsg1, were gifts from Dr. M. Wheelock.
Gel ®ltration chromatography For gel ®ltration analysis, con¯uent
cell monolayers (10 cm dishes) were rinsed 2 3 in ice cold phosphate-
buffered saline complete and scraped into 200 ml ice-cold 1% TTBS [1%
Triton X-100 (Sigma) 10 mM Tris pH 7.5, 140 mM NaCl, 5 mM
ethylenediamine tetraacetic acid, 2 mM ethyleneglycol-bis-(b-
aminoethylether)-N,N,N ¢,N ¢-tetraacetic acid, 1 mM phenylmethyl-
sulfonyl ¯uoride], or 1% OTBS [40 mM n-octyl, b-d-glucopyranoside
(Calbiochem, La Jolla, CA) in TBS]. Samples were vortexed 30 s and
cleared of insoluble material by centrifugation at 14,000 3 g, 15 min at
4°C. Samples were either used immediately or stored at ±70°C. Prior to
loading, a Superose-6 column (Amersham Pharmacia Biotech, Uppsala,
Sweden) was equilibrated with 25 ml TBS buffer containing either 1%
Triton X-100 or 40 mM octyl glucoside. Two hundred microliter
samples were loaded into a 200 ml loop and injected simultaneously with
the point of initiation of fraction 1. All gel ®ltration runs were
conducted at a ¯ow rate of 0.5 ml per min, and all fractions collected
were 0.5 ml. Fractions were analyzed immediately, or stored at ±70°C.
Sucrose density gradient sedimentation Ten percent to 20%
sucrose density gradients (in 1% TTBS with phenylmethylsulfonyl
¯uoride) were poured in 4 ml ultracentrifuge tubes (Beckman Coulter,
Fullerton, CA). Cell lysates were prepared as described above for gel
®ltration experiments, but were instead layered over density gradients.
For some experiments, lysates of cells expressing different isoforms were
mixed and layered over a single gradient so as to minimize intra-assay
variability. Samples were spun for 4 h at 60,000 r.p.m. (485,000 3 g
(max)) in an SW-60 rotor, and L8-M ultracentrifuge (Beckman Coulter).
Two hundred microliter fractions were collected by piercing the bottom
of the ultracentrifuge tube with an 18 gauge needle.
RESULTS AND DISCUSSION
The stoichiometry of the plakoglobin/Dsg1 complex does
not exceed 2:1, and the complexes formed between
plakoglobin and Dsg2 or Dsg3 are in approximately 1:1
stoichiometric ratios Previously, the stoichiometry of
plakoglobin/Dsg1 complexes in stable L-cell ®broblasts was
determined to be approximately 6:1 by immunodetection of
similar myc-epitope tags on the C-termini of each ectopic protein
(Kowalczyk et al, 1996) In order to extend this analysis by
examining the stoichiometry of complexes formed by the other
two isoforms of desmoglein, stable L-cell ®broblast lines were
generated and analyzed. These lines, coexpressing C-terminally
myc-tagged plakoglobin, with either C-terminally myc epitope-
tagged Dsg1, C-terminally myc tagged Dsg2, or a C-terminally
myc-tagged chimeric molecule comprising the extracellular domain
of E-cadherin and the intracellular domain of Dsg3 (Fig 1a), were
subjected to immunoprecipitation with anti-cadherin antibodies.
Analysis of stoichiometric ratios of complexed desmosomal
cadherins/catenins was made ®rst by anti-myc immunoblot of
precipitated components (Fig 1b). Scanning densitometric analysis
of anti-myc immunoblots suggested ratios of 6:1 and 1:1 for
plakoglobin/Dsg1 and plakoglobin/EcadDsg3, respectively. For
reasons unknown, several attempts to generate stable L-cell lines
expressing FLDsg3 were unsuccessful. Thus, in order to address the
possibility that the E-cadherin extracellular domain affected
assembly of EcadDsg3/plakoglobin complexes, transient
transfection/immunoprecipitation experiments were conducted in
which the plakoglobin-binding capacity of EcadDsg1 and
EcadDsg3 were compared with that of Dsg1 and Dsg3,
respectively. No difference between the full-length and chimeric
constructs was detectable (data not shown). In the case of
plakoglobin/Dsg2 complexes, very little plakoglobin was detected
in a complex with Dsg2, based on anti-myc immunoblot. To
determine whether this could be the result of limited plakoglobin
pools, triple lines were generated in which Dsg1, Dsg2 and
plakoglobin were coexpressed. Immunoprecipitation of complexes
from these lines suggested that with the same available pool of
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plakoglobin, myc detection revealed much higher plakoglobin/
Dsg1 than plakoglobin/Dsg2 ratios (Fig 1b).
To con®rm the results of the myc immunoblot experiments, the
same cell lines were subjected to metabolic labeling prior to
immunoprecipitation, and direct quantitation of cadherin/catenin
levels was made by autoradiography and analysis of 35S-labeled
proteins (Fig 1c). Results of the metabolic labeling experiments
suggested quite different cadherin/catenin ratios than were revealed
by anti-myc immunoblot. In the case of plakoglobin/Dsg1
complexes, ratios of 0.9:1 to 2:1 (after correction for met/cys
content) were calculated, depending on the individual cell line
analyzed (Fig 1c, and data not shown). Of three lines analyzed, one
(AF5) consistently showed ratios of 2:1, one (Dsg.Pg16) showed
ratios between 1:1 and 2:1, and one (Dsg.Pg19) showed ratios
between 0.9:1 and 1:1 by metabolic labeling. As none of these
values were in agreement with those obtained by the anti-myc
immunoblot approach, the immobilized metabolically labeled
proteins were then subjected to rehydration and immunoblotting
with anti-myc. This two-step detection method of the same
proteins allowed direct comparison of 35S signal with the result of
immunodetection of C-terminal epitope tags. These direct com-
parison experiments revealed that the 35S signal and myc signal
were in disagreement. Analysis of plakoglobin/Dsg2 ratios by
metabolic labeling revealed a ratio of 1:1 (Fig 1c), and analysis of
plakoglobin/EcadDsg3 ratios suggest 1:1 by both myc detection
and metabolic labeling (data not shown). This discrepancy was also
evident when longer metabolic labeling times of up to 13 h were
used to ensure that steady state had been achieved. Further
investigation using quantitative analysis of recombinant proteins
suggested that detection of the myc tag on these proteins occurs
with differing ef®ciency, such that a C-terminal myc tag on
plakoglobin is detected with 5 3 greater ef®ciency than is a C-
terminal myc-tag on Dsg1 (Bannon et al, 2001). It thus appears that
the metabolic labeling experiments more accurately re¯ect the true
stoichiometric ratios in these precipitated complexes.
Comparative analysis of the molecular size of plakoglobin/
desmoglein complexes corroborates the immuno-
precipitation results In order to investigate further the ability
of the three desmoglein isoforms to bind plakoglobin, plakoglobin/
desmoglein complexes were compared on the basis of their overall
molecular weight, using both gel ®ltration chromatography and
sucrose gradient sedimentation.
For the gel ®ltration experiments, L-cell lysates were subjected to
chromatographic separation on Superose 6 matrix. Fractions were
analyzed by immunoblotting for ectopic components. Lysates from
cell lines expressing Dsg1 and plakoglobin were ®rst compared with
cell lysates from lines expressing EcadDsg3 and plakoglobin
(Fig 2a, b), and subsequently compared with lysates from lines
expressing Dsg2 and plakoglobin (Fig 2c, d and data not shown).
When lysates were run either sequentially over the column, or
mixed together prior to loading, plakoglobin/Dsg1 complexes
consistently ran faster than did plakoglobin/EcadDsg3 complexes
This difference amounted to a mobility shift of 1.5 fractions. As
these proteins were solubilized in the presence of Triton X-100,
which forms large detergent micelles (average 90,000 kDa), it was
necessary to rule out the possibility that mobility differences were
masked by micelles, which had formed around the ectopic
complexes. The experiments were thus repeated in the presence
of 40 mM octyl glucoside (average micelle 8000 kDa) instead of
TX-100. Comparison of the rate of migration of plakoglobin/Dsg1
complexes with plakoglobin/Dsg2 complexes again suggested a
modest, but highly reproducible, difference of one fraction (Fig 2c,
d). As Dsg2 is larger than is Dsg1, this migratory shift likely
represents a difference in the overall size of complexes formed by
these two molecules. Use of gel ®ltration to determine nominal
molecular weights of these complexes is hampered by the fact that
the molecules under analysis are membrane proteins, and likely
retain association with parts of the cell membrane and/or other
membrane-associated factors. Indeed, subsequent analysis of puri-
®ed molecular size standards predicted the overall molecular weight
of all plakoglobin/desmoglein complexes to be in excess of
670 kDa, consistent with similar experiments in which classic
cadherin complexes were analyzed in MDCK cells and found to be
of much higher than expected size (Stewart and Nelson, 1997). The
gel ®ltration experiments were repeated three times, and in each
case, the shift in elution of the peak maximum was consistent.
As a second means of comparative evaluation of the overall size
of plakoglobin/desmoglein complexes, L-cell lysates were sub-
jected to sucrose density gradient sedimentation. Lysates containing
Dsg1, Dsg2, or EcadDsg3 complexes were layered singly or
together over sucrose gradients, and their migration measured by
immunoblot of collected fractions. Again, when Dsg1 containing
complexes were compared with Dsg2 or EcadDsg3 containing
complexes, the Dsg1 complexes migrated consistently faster (one to
two fractions), and in a broader peak, than did complexes formed
by the other desmoglein isoforms (Fig 2e, f, and data not shown).
These differences were highly reproducible over a minimum of
three replicates, and the data consistent with a previously reported
1:1 ratio for plakoglobin/Dsg2 obtained by sucrose sedimentation
(Chitaev et al, 1998). Correlation with molecular size standards
Figure 1. Immunoprecipitation analysis of stoichiometric ratios
among desmoglein/plakoglobin complexes. In order to analyze the
stoichiometry of complexes formed by the various desmosomal cadherin
isoforms and plakoglobin, stable L-cell lines were established expressing
these components, each with a C-terminal myc tag (a). (b) Four lines
expressing Dsg2 and plakoglobin, 743.M37, 743.J26, 743.B7, and
743.A1, were analyzed by immunoprecipitation with anti-6D8 anti-Dsg2
antibody, and immunoblot with 9E10 anti-myc antibody to detect C-
terminal myc-epitope tags. A cell line expressing Dsg1 and Dsg2 with
plakoglobin, 3299.C5 was subjected to immunoprecipitation with 982
anti-Dsg1 antibody, and 6D8 anti-Dsg2 antibody, followed by
immunoblot with 9E10. Four lines expressing EcadDsg3 and
plakoglobin, 790.2, 790.3, 790.4, and 790.12 were analyzed by
immunoprecipitation with DECMA anti-E-cadherin antibody, and
immunoblot with 9E10. (c) Stable lines expressing no ectopic proteins
(control), Dsg1 and plakoglobin (Dsg.Pg19), or Dsg2 and plakoglobin
(A6L) were metabolically labeled for 3 h and subjected to
immunoprecipitation with 982 or 6D8, respectively. Gels were
transferred to nitrocellulose and exposed to ®lm (35S). These blots were
subsequently rehydrated and subjected to 9E10 anti-myc immunoblot
(myc).
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suggests that this shift is consistent with a difference of one
plakoglobin monomer, or 80 kDa. Furthermore, the broader peak
may re¯ect the existence of complexes that contain either one or
two plakoglobin molecules. Interestingly, when EcadDsg3 com-
plexes were analyzed, two peaks were detected by immunoblot
with anti-E-cadherin antibody (Fig 2e, f). Based on the well-
characterized ability of the E-cadherin extracellular domain to form
readily both lateral and adhesive dimers, the ®rst peak (fractions 8±
10) probably represents complexes in which E-cadherin has
dimerized. As this complex would predict two cadherin and two
plakoglobin molecules, the sedimentation of the putative 2:1
plakoglobin/Dsg1 complex between the two EcadDsg3 peaks
correlates well with the existence of real differences in the ability of
Dsg1 vs. Dsg3 to bind plakoglobin. Thus, the results of the gel
®ltration experiments data suggest a size difference between
complexes formed by Dsg1 and those formed by Dsg2 or
EcadDsg3. Based on the previously discussed metabolic labeling
and myc immunoblot data, it appears that this difference likely
re¯ects a plakoglobin/Dsg1 stoichiometry of no greater than 2:1.
Taken together, the metabolic labeling, size exclusion chroma-
tography and sucrose gradient sedimentation experiments suggest a
modest but reproducible difference between the complexes formed
by Dsg1 and those formed by other desmoglein isoforms. By no
experimental approach did the Dsg2 or Dsg3 isoforms appear to
bind multiple plakoglobin monomers; thus it appears that Dsg1 has
a greater plakoglobin binding potential than do the other
desmoglein isoforms In addition, contrary to the originally
published immunoprecipitation/myc immunoblot experiments,
the data presented here suggest that the plakoglobin/Dsg1 complex
likely does not exceed a stoichiometric ratio of 2:1. This isoform-
speci®c binding of plakoglobin may be an important means by
which the desmogleins exert control over processes related to
differentiation, junctional assembly, and homeostasis in epithelia.
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